FendX Announces Proposed Name Change

FendX will rebrand as Marlin Health with a new CSE symbol on November 16, 2026.

What the company is saying

FendX Technologies Inc. is formally notifying investors of its intention to change its name to Marlin Health Inc. and to update its Canadian Securities Exchange trading symbol to 'MRLH'. The company specifies that the effective date for trading under the new name and symbol is anticipated to be November 16, 2026. The announcement emphasizes that no shareholder action is required and that existing share certificates remain valid. New ISIN (CA5709141017) and CUSIP (570914101) numbers for common shares are provided, with the CSE to publish a bulletin confirming the changes. The company clarifies that its OTCQB:FDXTF and FSE:E8D0 symbols will remain unchanged for now, though it intends to pursue a matching OTC symbol update. The release reiterates FendX's focus on developing protective surface coatings, including a nano-coating and a Foley catheter coating, and highlights its commitment to intellectual property in the surface protection sector. Carolyn Myers is named as Chief Executive Officer and Director, providing a direct point of contact for the transition.

What the data suggests

The announcement is administrative, providing exact details for the upcoming name and ticker change. The effective date for the new name and CSE symbol is set for November 16, 2026, with new ISIN and CUSIP numbers disclosed. No financial, operational, or project milestone data are included, and there is no discussion of business performance or outlook. The only hard facts are the procedural steps for the rebranding and the assurance that no shareholder action is needed. The company’s stated product focus and IP strategy are mentioned without supporting operational or financial evidence. The disclosure is complete for its administrative purpose but does not provide information on business fundamentals or near-term catalysts beyond the rebranding itself.

Analysis

The announcement is strictly administrative, detailing a planned name and ticker symbol change for FendX Technologies Inc. to Marlin Health Inc. All claims are either factual (the intention to change the name, the new ISIN/CUSIP, and the CEO's identity) or procedural (anticipated effective date, no shareholder action required). There is no promotional or exaggerated language, and no claims of operational, financial, or technological progress. The forward-looking elements (anticipated trading date, intention to change OTC symbol) are routine and procedural, not aspirational or hyped. No capital outlay or business benefit is claimed, and there is no attempt to link the name change to future performance. The gap between narrative and evidence is nonexistent; the language is proportionate and factual.

Risk flags

• ●The main risk is that a name and ticker change does not address or improve underlying business performance, and no operational or financial update accompanies this announcement. Investors have no new information on company strategy, execution, or financial health beyond the rebranding.
• ●There is a procedural risk that the anticipated effective date or symbol change could be delayed if the Canadian Securities Exchange bulletin or regulatory process is not completed as expected, though this is routine and low probability.
• ●The company’s stated intention to pursue an OTC Markets symbol change introduces minor uncertainty, as no timeline or process details are provided for that update.

Bottom line

This announcement is strictly procedural, confirming FendX Technologies Inc. will become Marlin Health Inc. with a new CSE symbol 'MRLH' effective November 16, 2026. No action is required from shareholders, and existing share certificates remain valid. The update does not provide any operational, financial, or strategic information beyond the rebranding, so it has no direct impact on the company’s business outlook or valuation. Investors should not expect any immediate business benefit from the name change alone. The most material fact is the new trading identity on the CSE; any substantive update on business performance or strategy would require a separate announcement.

Announcement summary

(CSE:FNDX) (OTCQB:FDXTF) (FSE:E8D0) FendX Technologies Inc. has announced its intention to change its name to Marlin Health Inc. and to change its symbol on the Canadian Securities Exchange to 'MRLH'. The Canadian Securities Exchange will publish a bulletin announcing the effective date of the name and symbol change, as well as the Company's new CUSIP and ISIN numbers. The Company anticipates that its common shares will commence trading under the new name, Marlin Health Inc., at market open on November 16, 2026, under the trading symbol 'MRLH'. No action is required by shareholders regarding the name change, and outstanding share certificates will not be affected or need to be exchanged. The Company's ISIN and CUSIP numbers for the common shares will change to CA5709141017 and 570914101, respectively. The Company's trading symbols on the OTC Markets and the Frankfurt Stock Exchange will remain unchanged at this time. However, the Company intends to pursue a change to its OTC Markets trading symbol to reflect the new corporate name and will provide an update accordingly. FendX Technologies Inc. is a surface protection company developing solutions to reduce the spread of harmful pathogens in everyday environments. The Company is advancing a portfolio of protective surface coatings, including a liquid-based nano-coating technology and a specialized Foley catheter coating. FendX is focused on building a robust intellectual property portfolio in the surface protection space and is committed to identifying and advancing new technologies and materials that enhance hygiene and safety across healthcare, consumer, and commercial settings. Carolyn Myers is the Chief Executive Officer and Director of the Company.

Disagree with this article?